Pharmafile Logo

Value-Based Cancer Care

Graduation day is celebrated by Lucid’s third Futures Academy cohort

Lucid’s Futures Academy is proud to release its most recent cohort of graduates into the business for the first of their two rotations.The Futures Academy begins with an eight-week intensive...

Lucid Group Communications Limited

- PMLiVE

Trump budget targets rebates, out-of-pocket costs

Biotech sector welcomes end to rebates, but worries about Medicare cuts

- PMLiVE

Optimism on Orkambi in England as talks to resume

Scotland's deal puts pressure on NHS England and NICE

AstraZeneca AZ

AZ signs $20m deal with Seres for microbiome project

Shares in Seres shot up 25% after the deal was announced

- PMLiVE

23andMe to offer type 2 diabetes testing kit

New report is powered by data from the company’s customers

- PMLiVE

The Communiqué Awards: what are judges looking for?

Judges in the Communiqué Awards reveal how to bring creativity and strategic thinking together

Cuttsy+Cuttsy named one of the Best Places to Work 2019 by Campaign

11 March 2019—Cuttsy+Cuttsy are honoured and extremely proud to be named one of the 50 Best Places to Work in 2019 by Campaign. The results were announced on 6th March...

Cuttsy + Cuttsy

- PMLiVE

Tecentriq gains first IO approval in triple negative breast cancer

A coup for Roche in IO field dominated by Keytruda

- PMLiVE

Shionogi planning HQ move from UK

Brexit understood to be main reason for switch

- PMLiVE

UK Biobank generates “largest open access resource of exome data”

Around 50,000 de-identifed genetic profiles available for research

- PMLiVE

Pegasus expands Pharma team with senior hires

Five new recruits support further growth of the Pharma & Life Sciences team

Inizio

- PMLiVE

Takeda’s Entyvio tops Humira in ulcerative colitis

Entyvio is important for post-merger Takeda

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links